SAN FRANCISCO, Feb 1 (Reuters) - The outlook is so bleak for a bankrupt biotechnology company briefly led by controversial investor Martin Shkreli that its management should be replaced by an...
from Reuters: Bankruptcy News http://ift.tt/1PuTQ5H
Tidak ada komentar:
Posting Komentar